National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
In English | En español
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
 Display for Print  New Search
 
Results: 1 -7 of 7         results per page
 View Search Criteria | Help With Results
           
Last Modified: 5/20/2008     First Published: 3/19/2008  

1.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase III
Biomarker/Laboratory analysis, Treatment
Active
18 and over
Other
CAN-NCIC-CO20
CO20, CAN-NCIC-CA182009, NCT00640471


2.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II, Phase I
Treatment
Active
18 and over
Pharmaceutical / Industry
CA182-025
2007-005097-31, NCT00594984


3.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II
Treatment
Active
18 and over
Pharmaceutical / Industry
CA182-006
NCT00355238


4.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II
Treatment
Active
18 and over
Pharmaceutical / Industry
CA182-026
NCT00633789


5.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase I
Biomarker/Laboratory analysis, Treatment
Active
20 and over
Pharmaceutical / Industry
CA182-012
NCT00390936


6.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase I
Biomarker/Laboratory analysis, Treatment
Active
18 and over
Pharmaceutical / Industry
CA182-008
NCT00435669


7.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase I
Treatment
Active
18 and over
Pharmaceutical / Industry
CA182-015
NCT00437424

   
  Display for Print   New Search

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov